Fatima M.
- Country
- France
- Department
- Service Oncologue Radiothérapie
Research Overview
Data & Insights
Has run more than one trial at 0 of 36 partner sites.
Specializations
Lung Cancer Therapeutics
This investigator specializes in innovative treatments for advanced non-small cell lung cancer (NSCLC), with particular focus on combination therapeutic approaches. Their research explores the integration of immunotherapy and radiation therapy in advanced disease stages.
- Advanced Stage NSCLC Treatment
- Immunotherapy Applications
- Combination Therapy Approaches
The investigator's work centers on optimizing treatment outcomes for patients with stage IIIB/IIIC/IV disease.
Immunotherapy Research
The investigator focuses on studying PD-1 inhibitor therapies, particularly exploring their efficacy in combination with other treatment modalities. Their research examines the therapeutic potential of pembrolizumab in first-line treatment settings.
- PD-1 Antagonist Applications
- First-line Treatment Strategies
- Immune Response Optimization
Their work emphasizes the development of targeted immunotherapy approaches for advanced lung cancer.
Multimodal Treatment Approaches
The investigator studies the integration of concurrent radiation therapy with immunotherapy and chemotherapy. Their research explores how these combined approaches impact overall survival rates in advanced lung cancer patients.
- Radiation-Immunotherapy Combinations
- Chemotherapy Integration
- Survival Outcome Assessment
Their research aims to establish optimal treatment sequences in multimodal therapy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.